Logo

American Heart Association

  2
  0


Final ID: Mo4022

Time Trends in Major Adverse Cardiovascular Events-Related Outcomes After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis on Sex Differences

Abstract Body (Do not enter title and authors here): Background: Percutaneous coronary intervention (PCI) is considered procedure of choice in patients with acute coronary syndrome (ACS). However, whether outcomes of PCI differ by sex remains uncertain.
Hypothesis: This systematic review and meta-analysis aims to evaluate potential sex-related differences in major adverse cardiovascular events (MACE) after PCI among ACS patients in different timeframes.
Methods: We conducted a systematic search of Pubmed, Embase, Cochrane, and ClinicalTrials databases to identify relevant randomized controlled trials with ACS patients undergoing PCI. The primary outcome of our article was study defined MACE components (all-cause mortality, cardiovascular mortality, myocardial infarction (MI), stroke, and need for revascularization). We evaluated Our outcomes in different timeframes, short-term (within 1 month after PCI), mid-term (1 month to 1 year), and long-term (>1 year). We used a random-effects model to estimate risk ratios (RR) and 95% confidence intervals (CI). Egger’s test and funnel plots were used to assess publication bias.
Results: Among 32 trials (78,846 patients; 59,491 men and 19,355 women), at short-term, PCI was associated with higher risk of all-cause mortality (RR=2.51, 95% CI 1.70; 3.71), MI (RR=1.33, 95% CI 1.00; 1.77), and stroke (RR=4.35, 95% CI 1.35; 14.04) in women compared with men. Concerning mid-term outcomes, the male group exhibited significantly lower risk of all-cause mortality, cardiovascular mortality, MI, and stroke compared to women group (RR=1.44, 95% CI 1.21; 1.72), (RR=1.29, 95% CI 1.00; 1.66), (RR=1.16, 95% CI 1.04; 1.28), and (RR=1.49, 95% CI 1.15; 1.93), respectively. Eventually, In the long-term, women were found to have a higher risk of both all-cause mortality (RR=1.27, 95% CI 1.16; 1.40) and cardiovascular mortality (RR=1.26, 95% CI 1.08; 1.48) compared to men. However, in terms of the need for revascularization, men had a higher risk compared to women (RR=0.87, 95% CI 0.77; 0.98).
Conclusion: In the meta-analysis of PCI related trials in ACS patients, women have a higher risk of cardiovascular events compared to men in different timeframes.
  • Shojaei, Shayan  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Ashraf, Haleh  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Nelson, John  ( CALIFORNIA CARDIOVASCULAR INSTITUTE , Fresno , California , United States )
  • Thachil, Rosy  ( Jacobi, Einstein COM , Bronx , New York , United States )
  • Iskander, Fady  ( MedStar Union Memorial Hospital , Maryland , Maryland , United States )
  • Khan, Safi  ( West Virginia University Hospitals , West Virginia , West Virginia , United States )
  • Nasir, Khurram  ( Houston Methodist , Houston , Texas , United States )
  • Hosseini, Kaveh  ( Tehran Heart center , Tehran , Iran (the Islamic Republic of) )
  • Mousavi, Asma  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Soleimani, Hamidreza  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Takaloo, Fatemeh  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Parhizkar Roudsari, Peyvand  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Salabat, Dorsa  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Shahmohammadi, Amirreza  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Mehrani, Mehdi  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Seilani, Parisa  ( Tehran Heart Center , Tehran , Iran (the Islamic Republic of) )
  • Author Disclosures:
    Shayan Shojaei: No Answer | Haleh Ashraf: No Answer | John Nelson: No Answer | Rosy Thachil: No Answer | Fady Iskander: DO NOT have relevant financial relationships | Safi Khan: No Answer | Khurram Nasir: DO NOT have relevant financial relationships | Kaveh Hosseini: DO NOT have relevant financial relationships | Asma Mousavi: DO NOT have relevant financial relationships | Hamidreza Soleimani: DO NOT have relevant financial relationships | Fatemeh Takaloo: No Answer | Peyvand Parhizkar Roudsari: DO NOT have relevant financial relationships | Dorsa Salabat: DO NOT have relevant financial relationships | Amirreza Shahmohammadi: DO NOT have relevant financial relationships | Mehdi Mehrani: No Answer | Parisa Seilani: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Long Term Management of the ACS Patient

Monday, 11/18/2024 , 01:30PM - 02:30PM

Abstract Poster Session

More abstracts from these authors:
Safety, Efficacy and Cardiovascular Benefits of Combination Therapy with Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Diabetes Mellitus:
A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Mousavi Asma, Syed Mushabbar, Kampaktsis Polydoros, Kuno Toshiki, Heffron Sean, Samsky Marc, Khorsand Askari Mani, Hosseini Kaveh, Shojaei Shayan, Soleimani Hamidreza, Semirani-nezhad Davood, Ebrahimi Pouya, Zafari Ali, Ebrahimi Rasoul, Roozbehi Khatere, Harrison Anil

Prognostic Value of Renal Function Biomarkers in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

Parhizkar Roudsari Peyvand, Tajdini Masih, Behnoush Amir Hossein, Moradi Ali, Sadaf Salehi, Keykhaei Mohammad, Hosseini Kaveh, Gomes Edward, Malhi Jasmine, Chew Christopher

You have to be authorized to contact abstract author. Please, Login
Not Available